Dexamethasone and lactoferrin induced PMN-MDSCs relieved inflammatory adverse events of anti-cancer therapy without tumor promotion
Li et al. show that dexamethasone and lactoferrin induced polymorphonuclear myeloid-derived suppressor cells relieve inflammatory conditions in mouse models with minimal effect on tumour growth. This work demonstrates promise for combating inflammatory adverse events during anti-cancer treatments.
Guardado en:
Autores principales: | Xing Li, Jie Chen, Yong-Jian Chen, Yi-Dan Qiao, Li-Yun Zhao, Nan Jiang, Xiang-Yuan Wu, Yan-Fang Xing |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a5f0da4bd4164d039b55198c4e4188a9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evaluation of the Anti-Inflammatory and Anti-Oxidative Effects of Therapeutic Human Lactoferrin Fragments
por: Yu Pan, et al.
Publicado: (2021) -
The Functional Role of Lactoferrin in Intestine Mucosal Immune System and Inflammatory Bowel Disease
por: Ning Liu, et al.
Publicado: (2021) -
Increasing oral PMN during experimental gingivitis and its reversal by prophylaxis
por: Prem K. Sreenivasan, et al.
Publicado: (2021) -
Enhanced Ferroelectric, Dielectric Properties of Fe-Doped PMN-PT Thin Films
por: Chao Feng, et al.
Publicado: (2021) -
LncRNA Snhg6 regulates the differentiation of MDSCs by regulating the ubiquitination of EZH2
por: Wei Lu, et al.
Publicado: (2021)